The Asia Pacific Virology Specimen Collection Market would witness market growth of 0.2% CAGR during the forecast period (2021-2027).
The reproduction process for viruses is similar to that of an assembly line, with different parts coming together to generate new viral particles. It is crucial to obtain the relevant samples in order to make an accurate diagnosis of viral illness. The speciman should reflect the systems that are involved in clinical disease and be taken during the acute phase of infection when viral concentrations are at their highest.
Immediately after the commencement of clinical signs, all specimens should be obtained. Once collected, all specimens should be kept in sterile containers and refrigerated as soon as possible. Ship with enough ice packs to keep the temperature at around 4 degrees Celsius.
In addition, one of the most hazardous and deadly viruses viz. COVID-19 was first identified in Wuhan, China. The COVID-19 then presented a significant obstacle for the growth of numerous developed as well as developing countries. According to the data shared in a report of the WHO, in 2020, COVID-19 caused more than 3.3 million deaths across the world. In such a scenario, the demand for virology specimen collection technology would rapidly increase across the region.
The China market dominated the Asia Pacific Virology Specimen Collection Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $457.5 million by 2027. The Japan market is anticipated to grow a CAGR of -0.4% during (2021 - 2027). Additionally, The India market would exhibit a CAGR of 0.8% during (2021 - 2027).
Based on Sample, the market is segmented into Nasopharyngeal Samples, Throat Samples, Cervical Samples, Nasal Samples, Blood Samples, Oral Samples, and Others. Based on Product Type, the market is segmented into Viral Transport Media, Specimen Collection Tubes, Blood Collection Kits and Swabs. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Virology Specimen Collection Market is Projected to reach USD 5.6 Billion by 2027, at a CAGR of 0.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trinity Biotech Plc, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, DiaSorin S.p.A., Vircell S.L., Quidel Corporation, Titan Biotech Ltd., Puritan Medical Products, Copan Italia s.p.a., and Hardy Diagnostics.
By Sample
By Product Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 